BCELUSD
Atreca, Inc.
A clinical-stage biopharmaceutical company in South San Francisco that mines the human immune system to discover new antibody medicines. Instead of starting from scratch, it profiles real patients' antibody responses to find antibodies that already fight disease, then turns the best ones into drug candidates for cancer and other illnesses, including a lead program called ATRC-101. The name Atreca echoes its approach—finding disease-fighting antibodies from actual human immune responses.
CUSIP: 04965G109HealthcareUS1 holder